All In Biotech

Drug Trial Radar · NCT03983980

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults

Last checked: Nov 20, 2026Latest source record: Jun 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 515 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

515

Actual

Start

Jun 6, 2019

Primary completion

May 13, 2020

Study completion May 29, 2020

Sponsor

Lead sponsor
Organon and CoIndustry
Sponsor type
Industry
Collaborators
IQVIA Biotech
First posted
Jun 12, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized double-blind vehicle-controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% once daily for the treatment of plaque psoriasis in adults. Approximately 500 adult subjects with plaque psoriasis will be randomized 2:1 to receive either tapinarof cream, 1% or matching vehicle cream once daily for 12 weeks.

Conditions

  • Plaque Psoriasis

Interventions

  • TapinarofDrug

    Tapinarof cream, 1%, applied once daily

  • Vehicle CreamDrug

    Vehicle cream applied once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of Subjects Who Achieve a Physician Global Assessment (PGA) Score of Clear (0) or Almost Clear (1) With a Minimum 2-grade Improvement From Baseline at Week 12. Analyses Were Done Using Multiple ImputationTime frame: Baseline to Week 12

Locations

50 sites in 2 countries. Site status is shown where the registry gives one.

  • Dermavant Investigative Site

    Fort Smith, Arkansas

  • Dermavant Investigative Site

    Fountain Valley, California

  • Dermavant Investigative Site

    Fremont, California

  • Dermavant Investigative Site

    Los Angeles, California

  • Dermavant Investigative Site

    Oceanside, California

  • Dermavant Investigative Site

    San Diego, California

  • Dermavant Investigative Site

    Santa Monica, California

  • Dermavant Investigative Site

    Denver, Colorado

  • Dermavant Investigative Site

    Boynton Beach, Florida

  • Dermavant Investigative Site

    Margate, Florida

  • Dermavant Investigative Site

    Miami, Florida

  • Dermavant Investigative Site

    Boise, Idaho

  • Dermavant Investigative Site

    Rolling Meadows, Illinois

  • Dermavant Investigative Site

    Plainfield, Indiana

  • Dermavant Investigative Site

    Overland Park, Kansas

  • Dermavant Investigative Site

    Louisville, Kentucky

  • Dermavant Investigative Site

    Owensboro, Kentucky

  • Dermavant Investigative Site

    Metairie, Louisiana

  • Dermavant Investigative Site

    Boston, Massachusetts

  • Dermavant Investigative Site

    Bay City, Michigan

  • Dermavant Investigative Site

    Detroit, Michigan

  • Dermavant Investigative Site

    Fort Gratiot, Michigan

  • Dermavant Investigative Site

    Fridley, Minnesota

  • Dermavant Investigative Site

    Omaha, Nebraska

  • Dermavant Investigative Site

    Las Vegas, Nevada

  • Dermavant Investigative Site

    East Windsor, New Jersey

  • Dermavant Investigative Site

    Hackensack, New Jersey

  • Dermavant Investigative Site

    Stony Brook, New York

  • Dermavant Investigative Site

    Wilmington, North Carolina

  • Dermavant Investigative Site

    Winston-Salem, North Carolina

  • Dermavant Investigative Site

    Beachwood, Ohio

  • Dermavant Investigative Site

    Bexley, Ohio

  • Dermavant Investigative Site

    Portland, Oregon

  • Dermavant Investigative Site

    Charleston, South Carolina

  • Dermavant Investigative Site

    Nashville, Tennessee

  • Dermavant Investigative Site

    Houston, Texas

  • Dermavant Investigative Site

    Pflugerville, Texas

  • Dermavant Investigative Site

    Plano, Texas

  • Dermavant Investigative Site

    San Antonio, Texas

  • Dermavant Investigative Site

    Webster, Texas

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.